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Abstract 
 
Background: Herbal medicines formulated as oils were believed to possess more powerful effects than their original plants in Iranian 
Traditional Medicine (ITM). One of the popular oils suggested for treatment of various indications was ginger oil. In the present study, to 
suggest a more convenient method of oil preparation (compared to the traditional method), ginger oil has been prepared according to both 
the traditional and conventional maceration methods and the volatile oil constituents have been compared.  
Material and Methods: Ginger oil was obtained in sesame oil according to both the traditional way and the conventional (maceration) 
methods. The volatile oil of dried ginger and both oils were obtained by hydro-distillation and analyzed by gas chromatography/mass 
spectroscopy.  
Results: Fifty five, fifty nine and fifty one components consisting 94 %, 94 % and 98 % of the total compounds were identified in the 
volatile oil of ginger, traditional and conventional oils, respectively.  
Conclusion: The most dominant compounds of the traditional and conventional oils were almost similar; however they were different 
from ginger essential oil which has also been to possess limited amounts of anti-inflammatory components. It was concluded that ginger 
oil could be prepared through maceration method and used for indications mentioned in ITM.  
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Introduction 
 
 Oils are old forms of medication used in Iranian Traditional Medicine (ITM) and they are believed to have presented more 
powerful effects than their original plants (Aghili Khorasani, 1999). Oils have been suggested as the most useful and suitable 
formulations for treatment of brain, nerve, uterus and stomach diseases; while topical application of medicines has been suggested to be 
more beneficial in the nervous organs compared to oral administration due to the changes in drugs during digestion. Oils have been 
proved to be effective as pain relievers and temperament (called ‘Mizaj” in ITM) modulators (Gharshi, 2008). 
 Ginger, Zingiber officinale (Zingiberaceae), is distributed worldwide (Mangprayool et al., 2013). It has an aromatic and pungent 
odor and is extensively used as spice in foods and drinks (Mangprayool et al., 2013; Razi, 1987). It has been employed as a traditional 
medicine around the world (Mangprayool et al., 2013).  
 Ginger has been used as carminative, laxative (Aghili Khorasani, 2008; Moamen Tonekaboni, 2007; Ibn sina, 2005), pain-
killing agents (Aghili Khorasani, 2008; Moamen Tonekaboni, 2007) and uterine pain reliever after labor in ITM (Chashti, 2004). It is 
also a liver and stomach tonic and is believed to clean phlegm (“Balgham”) and black bile (“Sauda”) gently (Aghili Khorasani 2008; 
Ansari shirazi, 1992; Ghasani, 2008).  
 In regard to recent studies, ginger has been used for the treatment of gastrointestinal disorders including indigestion, diarrhea 
(Mangprayool et al., 2013), dyspepsia Heidari et al., 2000; Heidari et al., 1997; Podlogar and Verspohl, 2012), 
 and nausea related to pregnancy, surgery or chemotherapy (Fleming, 2002; Mangprayool et al., 2013). It has also been used as 
carminative (Fleming, 2002), antioxidant (Fleming, 2002; Liu et al., 2013), anti-inflammatory (Fleming, 2002; Grzanna et al., 2005; 
Heidari et al.; Heidari et al., 1997; Podlogar and Verspohl, 2012a), anti-prostaglandin (Grzanna et al., 2005), anti-lipidemic (Fleming, 
2002) agent. Ginger has been applied for pain-killing (Mangprayool et al., 2013; Rizk, 2013), uterine smooth muscle relaxation 
(Buddhakala et al., 2008; Mangprayool et al., 2013) and dysmenorrhea (Kashefi et al., 2014; Ozgoli et al., 2009; Rahnama et al., 2010; 
Rahnama et al., 2012). It has reduced hypertension, nocturnal cough and dyspnea in asthmatic patients (Mangprayool et al., 2013) and 
has exhibited hepatoprotective activity (Liu et al., 2013). 
 In ITM, topical use of ginger oil has been reported to be useful for joint pain, joint stiffness (Chashti, 2007), lumbar and pelvic 
pain (Noorbakhsh; 2004) and spasms (Noorani, 2008). It has also been said to possess antinociceptive properties and ginger poultice was 
suggested as a brain, stomach and uterus tonic and a painkiller (Moamen Tonekaboni, 2007).. 
 Researches have shown that topical use of ginger essential oil is useful for joint pain (Sritoomma et al., 2014; Yip and Tam, 
2008); also the anti-inflammatory, antioxidant and antinociceptive properties of ginger oil have been demonstrated (Jeena et al., 2013). 
Regarding the long time usage of ginger oil in ITM as antinociceptive and antispasmodic agents as well as the recent reports about the 
anti-inflammatory, antioxidant, antinociceptive and antispasmodic activities of ginger oil, we decided to prepare the oil both through the 
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ITM manuscripts and the conventional maceration methods. The volatile oils derived from both oils were further compared for possible 
differences/similarities. 
 
Materials and Methods  
Plant material 
  
 Dried Zingiber officinale Roscoe rhizomes were provided from the local market (Aug 2014) and the scientific identity was 
confirmed by botanists at Traditional Medicine and Materia Medica Research Center (TMRC), Shahid Beheshti University of Medical 
Sciences, Tehran, Iran. A sample was kept for future reference (No 336 (HMS)). 
 
Preparation of ginger oil 
 
Traditional method (Ibn Abi Nasr, 1940) 
 
 Ginger rhizomes (100 g) were crushed and macerated in water (1000 mL) overnight. The mixture was heated until the volume 
reached half the initial. Then the mixture was filtered and sesame oil (500 mL) was added to the filtrate and the whole mixture was 
placed in a tin plated copper pot and heated gently until all water was evaporated. The oil was further filtered and centrifuged. The final 
transparent yellowish oil was kept in a refrigerator till the time of essential oil extraction. 
 
Conventional method 
  
 Crushed ginger rhizomes (100 g) were macerated in sesame oil (1:5) with continuous shaking for 7 days. The mixture was  
filtered and centrifuged afterwards. The final transparent yellowish oil was kept in a refrigerator. 
 
Essential oil extraction 
 
 The volatile oil of the dried ginger (50 g) (yield 1.9 %) and the oils obtained by the traditional and conventional methods (200 mL 
each) were obtained by hydrodistillation using a Clevenger type apparatus. 
 
GC/MS analysis 
  
 The constituents of the above volatile oils were identified by gas chromatography followed by mass spectrometry that is a 
solvent-free, efficient and rapid method to determine the volatile compounds (Yu et al., 2007). The analysis was performed on an Agilent 
5973 mass selective detector coupled with an Agilent 6890 gas chromatograph, equipped with a BPX5 capillary column SGE Analytical 
Science, Australia (30 m × 0.25 mm; film thickness 0.25 μm). The oven temperature was programmed 50-300 °C. The initial increasing 
rate was 3 °C per min.  
 After reaching 240 °C, the rate increased to 15 °C per min up to 300 °C. Helium was used as the carrier gas at a flow rate of 0.5 
mL/min. Injector temperatures was 290 °C. The MS operating parameters were: ionization voltage, 70 eV; ion source temperature, 220 
°C; mass range, 40-500.  The MSD ChemStation was used as the operating software. Retention indices were calculated by using retention 
times of n-alkanes (C8- C24) that were injected after the oil at the same conditions. Components of the oil were identified by comparison 
of their retention indices (RI) with those reported in the literature and also by computer matching with Wiley library. The fragmentation 
patterns of the mass spectra were also compared with those reported in the literature (Adams, 2001; McLafferty and Stauffer, 1989). 
 
 
Results 
 
 The composition of the volatile oils of ginger, traditional ginger oil and the conventional ginger oil with the retention times, 
retention indices and the percentage shares are presented in tables 1, respectively. More than 94 % of the components of ginger essential 
oil (55 compounds) have been identified. The most abundant compounds included α-zingiberene (15.20 %), β-phellandrene (13.51 %), 
camphene (7.69 %), E-E-α-farnesen (7.04 %), β-sesquiphellandrene (6.96 %) and ar-curcumene (5.60 %), which presented about 56 % of 
the essential oil compounds. α-Zingiberene (30.06 %), β-sesquiphellandrene (10.71 %), E-E-α-farnesene (9.75), β-bisabolene (6.53 %), 
ɣ-curcumene (5.90 %) and ar-curcumene (5.18 %) were the most dominant compounds in the essential oil of traditional ginger oil which 
included about 68 % of the oil. Around 94 % of the essential oil constituents were identified (59 compounds). 
 As for the essential oil of the conventional oil, about 98 % of the compounds have been authenticated (51 compounds) with α-
zingiberene (29.35 %), β-sesquiphellanderen (9.60 %), E-E-α-farnesen (9.26 %), β-phellandrene (8.87 %), β-bisabolene (5.83 %), ɣ-
curcumene (5.62 %) and ar-curcumene (5.33 %) as the most abundant compounds which comprised about 74 % of the essential oil. The 
most abundant compounds of each of the three essential oils are presented in table 2. The compounds which consisted more than 5 % of 
total volatile oil were considered as the most dominant constituents. 
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Table 1: Constituents of the essential oil of ginger rhizome, traditional and conventional ginger oils. 
NO Compound GR KI TO KI CO KI Standard KI* GR RT TO RT CO RT Type 
1  n- Octane - 800 - 800 - 5.82 - Other 
2  Hexanal - 807 - 802 - 6.13 - Other 
3  n- Nonane - 900 - 900 - 9.94 - Other 
4  α- Thyujene - 927 - 930 - 11.33 - MH 
5  Tricyclene 924 - 924 927 11.17 - 11.18 MH 
6  α- Pinene 935 935 934 939 11.74 11.71 11.72 MH 
7  Camphene 954 952 952 954 12.69 12.6 12.61 MH 
8  β- Pinene 981 - 981 979 14.06 - 14.06 MH 
9  Myrcene 992 992 992 991 14.65 14.63 14.63 MH 
10  n- Decana - 1000 - 1000 - 15.02 - MH 
11  α- Phellandrene 1011 1011 1010 1004 15.61 15.58 15.58 MH 
12  α- Terpinene 1021 1021 1021 1017 16.14 16.1 16.12 MH 
13  p- Cymene 1031 1030 1030 1025 16.64 16.6 16.61 MH 
14  Limonene - 1034 1034 1029 - 16.76 16.79 MH 
15  β- Phellandrene 1038 1036 1036 1030 17.03 16.89 16.91 MH 
16  Z-β- Ocimene - 1050 - 1037 - 17.63 - MH 
17  Benzen acetaldehyde - 1058 - 1042 - 18.04 - Other 
18  ɣ- Terpinene 1063 1058 1063 1060 18.31 18.3 18.31 MH 
19  Terpinolene 1090 - 1089 1089 19.7 - 19.69 MH 
20  p- Cymenene 1098 1068 1098 1085 20.14 20.12 20.14 MH 
21  Linalool 1106 1098 1106 1097 20.53 20.5 20.51 MO 
22  n- Nonanal - 1106 - 1101 - 20.85 - Other 
23  endo- Fenchol 1128 - 1128 1117 21.64 - 21.63 MO 
24  cis-p  Menth-2-en-1-ol 1132 - - 1122 21.85 - - MO 
25  Camphor 1159 - - 1146 23.15 - - MO 
26  Camphene hydrate 1166 - 1166 1150 23.51 - 23.5 MO 
27  Iso Borneol 1174 - 1174 1162 23.92 - 23.91 MO 
28  Borneol 1184 1183 1183 1169 24.4 24.35 24.36 MO 
29  Terpinen-4-ol 1190 1190 1190 1177 24.71 24.69 24.7 MO 
30  1- Dodecane - 1200 - 1190 - 25.19 - Other 
31  α- Terpineol 1206 1206 1205 1189 25.51 25.47 25.47 MO 
32  Citronellol 1234 1234 1234 1226 26.83 26.8 26.8 MO 
33  Neral 1249 - 1248 1238 27.5 - 27.49 MO 
34  Geraniol 1259 1258 1258 1230 27.98 27.94 27.94 MO 
35  Geranial 1278 - 1278 1267 28.91 - 28.90 MO 
36  Thymoquinone - 1264 - 1252 - 28.22 - MH 
37  2E- Decanal - 1273 - 1264 - 28.61 - MH 
38  Isobornyl acetate 1291 1292 1291 1286 29.52 29.52 29.51 MO 
39  2- Undecanone 1299 1300 1299 1294 29.89 29.88 29.88 Other 
40  Thymol - 1311 - 1299 - 30.39 - MO 
41  2E,4E- Decadienal - 1331 1331 1317 - 31.29 31.29 MO 
42  neo iso- Carvomenthyl acetate - 1355 - 1350 - 32.33 - MO 
43  Citronellyl acetate 1354 1354 - 1353 32.34 - 32.33  
44  Cyclosativene 1374 1375 1374 1371 33.22 33.21 33.22 SH 
45  α- Copaene 1381 1381 1381 1377 33.50 33.50 33.50 SH 
46  Geranyl acetate 1385 1384 1384 1381 33.70 33.64 33.64 MO 
47  β- Elemene 1394 1400 1401 1391 34.11 34.11 34.10 MH 
48  7-epi- Sesquithujene 1405 1405 1404 1391 34.55 34.54 34.54 SH 
49  Methyl eugenol - 1414 - 1404 - 34.91 - PHENYL 
50  E- Caryophyllene - 1418 - 1419 - 35.10 - SH 
51  α- Funebrene 1425 - 1424 1403 35.40 - 35.38 SH 
52  trans- Caryophyllene - - 1427 1419 - - 35.47 SH 
53  ɣ- Elemene 1435 - 1435 1437 35.81 - 35.81 SH 
54  α-trans- Bergamotene 1437 1437 - 1435 35.91 35.90 - SH 
55  α- Himachalene 1457 1459 1456 1441 36.73 36.70 36.71 SH 
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NO Compound GR KI TO KI CO KI Standard KI* GR RT TO RT CO RT Type 
56  allo- Aromadendrene 1469 1468 1468 1460 36.83 36.79 36.81 SH 
57  α- Acrodiene 1465 1465 1464 1466 37.09 37.04 37.06 SH 
58  ɣ- Curcumene 1484 1483 1483 1483 37.87 37.80 37.83 SH 
59  ar- Curcumene 1490 1488 1488 1481 38.12 38.02 38.04 SH 
60  β- Selinene 1494 1494 1493 1493 38.28 38.27 38.25 SH 
61  α- Zingiberene 1505 1501 1503 1494 38.74 38.57 38.65 SH 
62  Epizonarene - 1504 - 1502 - 38.69 - SH 
63  E-E-α- Farnesene 1511 1509 1511 1506 38.98 38.86 38.90 SH 
64  β- Bisabolene 1516 1514 1514 1506 39.18 39.07 39.11 SH 
65  ɣ- Cadinene 1524 1523 1523 1514 39.50 39.42 39.44 SH 
66  δ- Cadinene 1527 1526 1526 1523 39.62 39.56 39.58 SH 
67  β- Sesquiphellandrene 1534 1532 1532 1523 39.89 39.77 39.80 SH 
68  Selina-3,7(11)-diene 1548 1552 1547 1547 40.46 40.58 40.42 SH 
69  trans- Cadinene ether 1557 - - 1559 40.80 - - SO 
70  E- Nerolidol 1567 1567 1567 1563 41.20 41.19 41.19 SO 
71  Hexadecane - 1600 - 1600 - 42.47 - Other 
72  Dodecanoic acid 1572 - - 1567 41.39 - - Other 
73  epi-α- Cadinol 1639 - - 1640 43.97 - - SO 
74  α- Muurolol 1656 - - 1646 44.59 - - SO 
75  β- Eudesmol 1671 1671 1670 1651 45.17 45.15 45.14 SO 
76  n- Hexanoic acid - 1970 - - - 55.47 - Other 
77  Hexadecanoic acid,ethyl ester - 1998 - - - 56.38 - Other 
 
MH: Monoterpene Hydrocarbons; MO: Oxygenated Monoterpenes; SH: Sesquiterpene Hydrocarbons; SO: Oxygenated Sesquiterpenes. 
*: Adams, 2001; McLafferty and Stauffer, 1989) 
 
 
Table 2: The most abundant constituents of the essential oils. 
 Compounds 
Oil 
α- 
zingiberen
e 
Β-
phellandren
e 
camphen
e 
E-E-α- 
farnese
n 
β- 
sesquiphellandren
e 
ar- 
curcumen
e 
β- 
bisabolen
e 
ɣ- 
curcumen
e 
Ginger oil 15.20 13.51 7.69 7.04 6.96 5.60 - - 
Traditional 
oil 30.06 - - 9.75 10.71 5.18 6.53 5.90 
Conventiona
l oil 29.35 8.87 - 9.26 9.60 5.33 5.83 5.62 
-: compound comprised less than 5 % of the essential oil 
 
 
Discussion 
 
 There are previous studies about the anti-inflammatory effects of Zingiber officinale volatile oil and some of its constituents. 
Jeena et al. have analyzed ginger essential oil to find α-zingiberene, ar-curcumene and α-sesquiphellandrene as the most dominant 
components. They have evaluated the effects of the oil in a carrageenan, dextran and formalin model for inducing chronic inflammation. 
The results demonstrated significant reduction in acute inflammation (Jeena et al., 2013. Ginger essential oil (rich in ar-curcumene) has 
also shown anti-inflammatory properties through affecting leukocyte migration both in vitro and in vivo (de Melo et al., 2011). The 
volatile oil of Zingiber officinale with zingiberene, ar-curcumene, β-bisabolene and α-sesquiphellandrene  as the major components, has 
shown to be effective in decreasing severity and extent of inflammation in a rat model of colitis (Rashidian et al., 2014). In another study, 
evaluating the volatile oil of ginger (with zingiberene as the dominant composition) in vitro and in vivo has suggested the impact of the 
oil in cell-mediated immune response and nonspecific proliferation of T-cell which might play a role in inflammatory conditions (Zhou et 
al., 2006). 
 
Conclusions 
 
 The anti-inflammatory properties of ginger volatile oil and some of its constituents like zingiberene (Jeena et al., 2013; Johji et 
al., 1988; Mustafa et al., 1993; Rashidian et al., 2014; Türkez et al., 2014; Zhou et al., 2006), sesquiphellandrene (Jeena et al., 2013; 
Rashidian et al., 2014) and curcumene (de Melo et al., 2011; Jeena et al., 2013; Podlogar and Verspohl, 2012; Rashidian et al., 2014) () 
somehow explain the application of ginger oil in ITM for various indications. As it is shown in table 2, except for β-phellandrene, other 
dominant components of the volatile oil of both traditional and conventional oils almost have similar amounts. The conventional method 
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of oil preparation is more convenient than the traditional method which needs special cupper made pot that need to be tin plated prior to 
use and the conventional maceration method seems more convenient compared to the multi-step traditional method of oil preparation. It 
could be concluded that instead of following the traditional method of ginger oil preparation, it is possible and more convenient to 
prepare ginger oil according to the conventional method so that it could be used in the numerous indications suggested in ITM. 
 As observed in the present study, the amount of zingiberene in both traditional and conventional ginger oil was approximately 
two times compared to ginger essential oil; while the amount of sesquiphellandrene in both traditional and conventional ginger oil was 
nearly one and a half times in comparison with ginger essential oil. On the other hand, unlike traditional and conventional oils, ginger 
essential oil didn’t seem to possess curcumene and β-bisabolene. Regarding that zingiberene, sesquiphellandrene, curcumene and β-
bisabolene are important anti-inflammatory agents, it could be suggested that the traditional and conventional ginger oils possess more 
anti-inflammatory effects than ginger essential oil and it could be used instead of ginger essential oil as anti-inflammation agents. 
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